Transcutaneous Electrical Acupoint Stimulation for Postoperative Cognitive Dysfunction

October 27, 2020 updated by: Lijuan Xi, Subei People's Hospital of Jiangsu Province

Transcutaneous Electrical Acupoint Stimulation for Postoperative Cognitive Dysfunction in Geriatric Patients With Gastrointestinal Tumor

Postoperative cognitive dysfunction (POCD) is one of the common complications of cancer patients after operation with a 8.9%-46.1% incidence, which severely affecting patients' postoperative recovery, increasing the medical cost, affecting the social function of patients, reducing the quality of life and increasing the mortality.

Surgical trauma and perioperative pain can induce systematic inflammatory response and release systematic inflammatory mediators, which can enter the central nervous system (CNS) and lead to CNS inflammatory. In order to prevent the development of POCD among elder patients, the discovery of effective interventions reducing perioperative pain and inflammatory response is important.

Transcutaneous Electrical Acupoint Stimulation (TEAS) is a non-invasive alternative to needle-based electro-acupuncture (EA). It combines the acupuncture and transcutaneous electrical nerve stimulation (TENS) by pasting the electrode piece on the acupoint instead of sticking the needles on the skin. TEAS can trigger the release of endogenous neurotransmitters, releasing endogenous analgesic substances, such as endorphins. TEAS also can reduce the intraoperative anesthetic consumption, postoperative pain score, postoperative nausea and vomiting (PONV), and improve the postoperative recovery of patients. Recently, TEAS was found to improve the cognitive function of geriatric patients with silent lacunar infarction. However, the current TEAS mainly focus on intraoperative. The effect of perioperative TEAS on POCD is not clear.

Here, the effect of TEAS on POCD in geriatric adults undergoing radical resection of gastrointestinal tumors under general anesthesia was investigated to determine whether TEAS can decrease perioperative pain or inflammatory response to prevent the occurrence of POCD and to find out the relationship among perioperative TEAS, inflammatory response, postoperative pain, and POCD preliminarily.

Study Overview

Detailed Description

This study aims to evaluate the effect of perioperative transcutaneous electrical acupoint stimulation (TEAS) on postoperative cognitive dysfunction (POCD) in elderly patients who were diagnosed with gastrointestinal tumor and received radical resection of gastrointestinal tumors under general anesthesia and to determine the relationship among perioperative TEAS, inflammatory response, postoperative pain, and POCD preliminarily.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Yangzhou, Jiangsu, China, 225001
        • Northern Jiangsu People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 90 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients aged 60 years or older;
  2. Patients were diagnosed with gastrointestinal tumor and received radical; resection of gastrointestinal tumors under general anesthesia in Subei people's hospital of Jiangsu province;
  3. The patients understood the research content and signed the informed consent form;
  4. American Society of Anesthesiology (ASA) score I-III;
  5. No frailty before operation;
  6. D-dimer was normal before the operation

Exclusion Criteria:

  1. Patients with cognitive dysfunction before the operation or patients with previous history of cognitive dysfunction, dementia and delirium;
  2. Patients with a history of severe depression, schizophrenia and other mental and nervous system diseases or taking antipsychotic or antidepressant drugs in the past;
  3. Patients with severe hearing or visual impairment due to eye or ear diseases without assistive tools;
  4. Patients who are unable to communicate or have difficulty communicating;
  5. According to the definition of "China chronic disease and its risk factors monitoring report (2010)" (male average daily pure alcohol intake ≥ 61g, female average daily pure alcohol intake ≥ 41g, alcohol volume (g) = alcohol consumption (ML) × alcohol content% × 0.8);
  6. Patients who were hospitalized for three months or more before surgery or who had received surgical treatment within three months;
  7. Patients who can't take care of themselves or are physically disabled and unable to carry out nerve function test;
  8. Patients with severe heart, liver and renal failure;
  9. Patients with hypoxemia (blood oxygen saturation < 94%) more than 10 minutes during operation;
  10. Patients admitted to ICU after operation;
  11. Patients who quit or died due to noncooperation or sudden situation;
  12. Patients who already participate in other clinical studies which may influence this study;
  13. Patient who underwent emergency surgery;
  14. Patient had a history of recent or conventional acupuncture treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Transcutaneous electrical acupoint stimulation group
Transcutaneous electrical acupoint stimulation group patients received Transcutaneous electrical acupoint stimulation (Neiguan [PC6], Yintang [GV 29], Zusanli [ST36]) for 30 min before the induction of anaesthesia until the end of the surgery and the night before operation, the first, second and third night after operation 30 min once a day with an altered frequency 2/100 Hz, disperse-dense waves, adjusted electricity intensity which was less than 10 mA.
According to the traditional Chinese medicine 15,three acupuncture points were selected as the target points: bilateral Neiguan ,Yintang and bilateral Zusanli.. A transcutaneous electrical stimulator was used to provide an altered frequency 2/100 Hz,disperse-dense waves,and adjusted intensity which was less than 10mA.
NO_INTERVENTION: Control group
In Control group, except the electronic stimulation was not applied, the treatment was the same as the Transcutaneous electrical acupoint stimulation group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mini-Mental State Examination score
Time Frame: In the morning of the day before operation
Assess the cognitive function of the patient,the minimum value is 0,and the maximum value is 30, higher scores mean a better outcome.
In the morning of the day before operation
Mini-Mental State Examination score
Time Frame: Three days after operation
Assess the cognitive function of the patient,the minimum value is 0,and the maximum value is 30, higher scores mean a better outcome.
Three days after operation
C reactive protein
Time Frame: The day before operation.
Assess the inflammatory reaction of the patient
The day before operation.
C reactive protein
Time Frame: The 1st day after the operation.
Assess the inflammatory reaction of the patient
The 1st day after the operation.
C reactive protein
Time Frame: The 3rd day after the operation.
Assess the inflammatory reaction of the patient
The 3rd day after the operation.
Interleukin-6
Time Frame: The day before operation.
Assess the inflammatory reaction of the patient
The day before operation.
Interleukin-6
Time Frame: The 1st day after the operation.
Assess the inflammatory reaction of the patient
The 1st day after the operation.
Interleukin-6
Time Frame: The 3rd day after the operation.
Assess the inflammatory reaction of the patient
The 3rd day after the operation.
S100 calcium-binding protein β
Time Frame: The day before operation.
Assess the inflammatory reaction of the patient
The day before operation.
S100 calcium-binding protein β
Time Frame: The 1st day after the operation.
Assess the inflammatory reaction of the patient
The 1st day after the operation.
S100 calcium-binding protein β
Time Frame: The 3rd day after the operation.
Assess the inflammatory reaction of the patient
The 3rd day after the operation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Rating Scale score
Time Frame: The day before operation
Assess the pain score of the patient,the minimum value is 0,and the maximum value is 10, higher scores mean a worse outcome.
The day before operation
Numeric Rating Scale score
Time Frame: The day of operation
Assess the pain score of the patient,the minimum value is 0,and the maximum value is 10, higher scores mean a worse outcome.
The day of operation
Numeric Rating Scale score
Time Frame: The 1st day after the operation.
Assess the pain score of the patient,the minimum value is 0,and the maximum value is 10, higher scores mean a worse outcome.
The 1st day after the operation.
Numeric Rating Scale score
Time Frame: The 2rd day after the operation.
Assess the pain score of the patient,the minimum value is 0,and the maximum value is 10, higher scores mean a worse outcome.
The 2rd day after the operation.
Numeric Rating Scale score
Time Frame: The 3nd day after the operation.
Assess the pain score of the patient,the minimum value is 0,and the maximum value is 10, higher scores mean a worse outcome.
The 3nd day after the operation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Daorong Wang, Ph.D., Clinical Medical College of Yangzhou University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2020

Primary Completion (ACTUAL)

September 30, 2020

Study Completion (ACTUAL)

September 30, 2020

Study Registration Dates

First Submitted

October 16, 2020

First Submitted That Met QC Criteria

October 22, 2020

First Posted (ACTUAL)

October 28, 2020

Study Record Updates

Last Update Posted (ACTUAL)

October 29, 2020

Last Update Submitted That Met QC Criteria

October 27, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Underlie results in a publication

IPD Sharing Time Frame

starting in October 2020

IPD Sharing Access Criteria

Study which was used to do meta analyse

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Cognitive Dysfunction

Clinical Trials on Transcutaneous electrical acupoint stimulation

3
Subscribe